[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354580-105":59,"doc-detail-354580-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","diabetes-mellitus-as-an-independent-risk-factor-for-unfavorable-prognosis-in-patients-with-small-cell-lung-cancer-original-article-open-access","Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer - Original Article - Open Access","","Type 2 diabetes mellitus (DM) is associated with cancer development and poor survival, yet its effect on small cell lung cancer (SCLC) outcomes remains unclear. This retrospective cohort study evaluated whether DM influences long-term prognosis in extensive-stage SCLC patients treated with immune checkpoint inhibitors and chemotherapy. Clinical data were analyzed with Cox proportional hazards models, comparing progression-free survival and overall survival between patients with and without DM.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diabetes-mellitus-as-an-independent-risk-factor-for-unfavorable-prognosis-in-patients-with-small-cell-lung-cancer-original-article-open-access/354580/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diabetes-mellitus-as-an-independent-risk-factor-for-unfavorable-prognosis-in-patients-with-small-cell-lung-cancer-original-article-open-access/354580.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about diabetes and small cell lung cancer?","Question",{"text":113,"@type":114},"Whether type 2 diabetes mellitus (DM) is associated with clinical outcomes and long-term prognosis in patients with extensive-stage small cell lung cancer (ES-SCLC).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the impact of DM on survival assessed in this study?",{"text":118,"@type":114},"A retrospective cohort analysis compared patients with and without DM using Cox proportional hazards regression, evaluating progression-free survival (PFS) and overall survival (OS).",{"name":120,"@type":111,"acceptedAnswer":121},"What were the main survival findings for ES-SCLC patients with DM?",{"text":122,"@type":114},"Patients with DM had significantly shorter median PFS and median OS than those without diabetes, and multivariate analysis showed DM as an independent risk factor for shorter median OS.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354580,1790169085,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Thoracic Cancer  \nORIGINAL ARTICLE  OPEN ACCESS   \nDiabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer  \nRui Yan | Patiguli Yisilamu | Yang Ge | Weiwei Zhou   \nBeijing Chao-Yang Hospital Department of Oncology, Capital Medical University, Beijing, China  \nCorrespondence: Weiwei Zhou ([zhouweiwei@ccmu.edu.cn](zhouweiwei@ccmu.edu.cn))  \nReceived: 13 April 2026 | Revised: 10 July 2026 | Accepted: 21 July 2026  \nKeywords: chemotherapy | diabetes mellitus | ES-SCLC | immune checkpoint inhibitors  \nABSTRACT  \nBackground: Type 2 diabetes mellitus (DM) is implicated in cancer development and associated with poor survival in patients with cancer. However, the impact of DM on the outcome of small cell lung cancer (SCLC) remains unknown. This study investigated the correlation between DM and clinical outcomes and long-term prognosis of patients with extensive-stage small cell lung cancer (ES-SCLC) .  \nMethods: This retrospective cohort study was conducted using the medical records of patients with ES-SCLC treated with immune checkpoint inhibitors (ICIs) and chemotherapy. The demographic and clinical characteristics were retrospectively analyzed. Univariate and multivariate analyses were performed using Cox proportional hazards regression to evaluate the impact of the clinical characteristics on survival. Progression-free survival (PFS) and overall survival (OS) were compared between patients with or without DM.  \nResults: Of the 91 patients with ES-SCLC, 32 were diagnosed with DM before ES-SCLC (35.2%) . Patients with DM had significantly shorter median PFS (6 vs. 15 months, p = 0.026) and median OS (12 vs. 22 months, p = 0.013) than those without diabetes, despite receiving comparable chemoimmunotherapy. Multivariate cox regression analysis showed that DM was an independent risk factor for shorter mOS (HR 2.05, 95% CI 1.02–4.13, p = 0.044) .  \nConclusions: Patients with ES-SCLC and comorbid diabetes exhibited significantly shorter OS and PFS compared with those without diabetes. DM serves as an independent adverse prognostic risk factor for ES-SCLC.  \n1 | Introduction  \nSmall cell lung cancer (SCLC) is a high-grade neuroendocrine carcinoma that accounts for approximately 15% of lung cancers. SCLC is characterized by early metastasis, a high growth rate, rapid resistance, and poor survival rates [1] . Immune checkpoint inhibitors (ICIs) combined with chemotherapy are the standard first-line treatment for extensive-stage SCLC (ES-SCLC) . Nevertheless, most patients relapse within 12 months, and the  \n5-year survival rate is very low despite the use of multiple regimens [2] .  \nType 2 diabetes mellitus (DM) is characterized by glycemia due to insulin resistance followed by insufficient insulin production from pancreatic β cells [3] . Increasing evidence has shown that DM is associated with cancer development [4] . DM is linked to relative risk ratios of 2.0–2.5 for malignancies of the liver, pancreas, and endometrium and 1.2–1.5 for colon, bladder, and  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2026 The Author(s) . Thoracic Cancer published by John Wiley & Sons Australia, Ltd.  \nThoracic Cancer, 2026; 17:e70378 1 of 9  \n[https://doi.org/10.1111/1759-7714.70378](https://doi.org/10.1111/1759-7714.70378)  \nFIGURE 1 | Study flowchart.  \nbreast cancers [5] . Moreover, DM is associated with an adverse clinical course, treatment complications, and/or lower survival in patients with cancer [6–8] .  \nMultiple factors may also contribute to the progression of DM. The inflammatory and endocrine effects of obesity, a major risk factor for DM, have been proposed as the central mechanisms underlying the association between diabetes and cancer [9] . Ot","cbCaiafJp0DUn0e3","https://ap.wps.com/l/cbCaiafJp0DUn0e3","pdf",633983,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Methods and Materials\n## Patients","[{\"question\":\"What question does the study address about diabetes and small cell lung cancer?\",\"answer\":\"Whether type 2 diabetes mellitus (DM) is associated with clinical outcomes and long-term prognosis in patients with extensive-stage small cell lung cancer (ES-SCLC).\"},{\"question\":\"How was the impact of DM on survival assessed in this study?\",\"answer\":\"A retrospective cohort analysis compared patients with and without DM using Cox proportional hazards regression, evaluating progression-free survival (PFS) and overall survival (OS).\"},{\"question\":\"What were the main survival findings for ES-SCLC patients with DM?\",\"answer\":\"Patients with DM had significantly shorter median PFS and median OS than those without diabetes, and multivariate analysis showed DM as an independent risk factor for shorter median OS.\"}]","Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer - Original Article - Open Access | PDF",1790112257,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eeab5c62adce8ac1938c0f0d2cd936fe.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/282388b4a4c8c8541bc36a9f88e8b63d.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff73fd4eb00612140327df432a758bd9.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c76f69b31c714816976035ed2538df75.webp",980,1287]